ArticleBMC endocrine disorders2018

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report.

A Ciresi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.